Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Evolving Therapeutic Strategies in Neuroendocrine Neoplasms: A New Era of Personalized Therapies.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 26, 2026
Ersodetug for Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 26, 2026
[177Lu]Lu-dota-tate radioligand therapy for advanced pancreatic neuroendocrine tumours.
Journal: The Lancet. Oncology
Published: April 19, 2026
Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy.
Journal: Endocrine pathology
Published: September 13, 2025
Mammary small cell neuroendocrine carcinomas that showed excellent pathologic response following etoposide-based neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: August 29, 2025
First Autopsy-confirmed Complete Remission of Metastatic Neuroendocrine Neoplasm of Tailgut Cyst After a Single Cycle of Alpha-Peptide Receptor Radionuclide Therapy With [ 225 Ac]Ac-DOTA-LM3.
Journal: Clinical nuclear medicine
Published: June 23, 2025
Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysis.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
Journal: The New England journal of medicine
Published: September 16, 2024
Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study.
Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 17, 2024
Striking Size Reduction of Rapidly Growing Pancreatic Neuroendocrine Carcinoma Metastatic Nodal Conglomerate After Only 2 Cycles of 177 Lu-DOTATATE.
Journal: Clinical nuclear medicine
Published: June 13, 2022
Rapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine Tumors.
Journal: Pancreas
Published: August 16, 2021
Last Updated: 09/26/2026